Public Health Policy and Outbreak Response: Difference between revisions
Created page with "== Subtopics == === Kerala Public Health Response Model === Details coordinated response strategies including rapid containment, surveillance, and healthcare preparedness. === Infection Prevention and Control === Focuses on hospital infection control protocols and community-level prevention strategies. === Risk Communication Strategies === Explores public messaging, misinformation management, and communication frameworks during outbreaks. === Community..." |
No edit summary |
||
| (One intermediate revision by the same user not shown) | |||
| Line 1: | Line 1: | ||
== | === [[Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’|Improving clinical care of patients in Nipah outbreaks: moving beyond ‘compassionate use’]] === | ||
'''2024''' - The Lancet Regional Health - Southeast Asia | |||
This paper discusses strategies to improve the clinical care for patients in Nipah outbreaks, focusing on enhancing early case detection, optimizing supportive care, adopting a syndromic approach, and exploring innovative trial designs. The goal is to better equip healthcare systems in Nipah-endemic regions to manage current and future outbreaks. | |||
=== [[ | === [[A short communication of Nipah virus outbreak in India: An urgent rising concern|A short communication of Nipah virus outbreak in India: An urgent rising concern]] === | ||
'''2022''' - Annals of Medicine and Surgery | |||
This paper discusses the recent re-emergence of Nipah virus (NiV) in India's Kozhikode district, causing the death of a 12-year-old boy. The authors aim to suggest recommendations to contain and mitigate the severe impact of the virus on affected populations. | |||
=== [[ | === [[A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses|A Brighton Collaboration standardized template with key considerations for a benefit/risk assessment for a soluble glycoprotein vaccine to prevent disease caused by Nipah or Hendra viruses]] === | ||
'''2021''' - Vaccine | |||
A protein vaccine for Nipah and Hendra viruses is under clinical evaluation in a Phase 1 study. The paper discusses the standardized template to describe key considerations for the benefit-risk assessment of this type of vaccine. | |||
=== [[ | === [[Community willingness to participate in a Nipah vaccine trial in Bangladesh|Community willingness to participate in a Nipah vaccine trial in Bangladesh]] === | ||
'''2025''' - Vaccine | |||
This paper explores people's knowledge about Nipah virus and their willingness to participate in a vaccine trial in Bangladesh. | |||
[[ | === [[Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and preexisting severe henipaviruses|Understanding and addressing the global impact: A systematic review and cross-sectional bibliometric analysis of Langya henipavirus and preexisting severe henipaviruses]] === | ||
'''2025''' - Journal of Infection and Public Health | |||
This paper provides an overview of the scientific landscape, highlights research focus areas, and outlines potential future investigations on Langya henipavirus. It was done via a systematic review and bibliometric analysis over the past two decades. | |||
=== [[Henipaviruses: an expanding global public health concern?|Henipaviruses: an expanding global public health concern?]] === | |||
'''2022''' - GeroScience | |||
This paper reviews the pathogenicity and interaction with the human immune system of Nipah virus (NiV) and Hendra virus (HeV), highly pathogenic zoonotic viruses that can cause severe disease in humans and various mammalian species. | |||
=== [[The rising threat of Nipah virus: a highly contagious and deadly zoonotic pathogen|The rising threat of Nipah virus: a highly contagious and deadly zoonotic pathogen]] === | |||
'''2025''' - Virology Journal | |||
This paper reviews the epidemiology, clinical features, and modes of transmission of Nipah virus infection, its geographical distribution, and endemic regions. | |||
=== [[A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: components and costs|A large-scale behavior change intervention to prevent Nipah transmission in Bangladesh: components and costs]] === | |||
'''2017''' - BMC Research Notes | |||
This paper measures the cost of an intervention to prevent Nipah transmission in Bangladesh and estimates the cost of scaling it up in districts where spillover has been identified. | |||
=== [[A review of the nipah virus|A review of the nipah virus]] === | |||
'''2024''' - Journal of Health, Population and Nutrition | |||
This paper reviews the Nipah Virus (NiV), an emerging zoonotic disease primarily found in Southeast Asian regions with the highest number of cases in Bangladesh and India. The virus has a high fatality rate and there is no approved treatment or vaccine. | |||
=== [[Possible high risk of transmission of the Nipah virus in South and South East Asia: a review|Possible high risk of transmission of the Nipah virus in South and South East Asia: a review]] === | |||
'''2023''' - Tropical Medicine and Health | |||
This paper reviews the epidemiology, pathogenesis, molecular surveillance, transmission dynamics, genetic diversity, reservoir host, clinical characteristics, and phylogenetics of Nipah virus in South and South East Asia. | |||
=== [[Controlling Nipah virus encephalitis in Bangladesh: Policy options|Controlling Nipah virus encephalitis in Bangladesh: Policy options]] === | |||
'''2015''' - Journal of Public Health Policy | |||
This paper discusses policy options for controlling Nipah virus encephalitis in Bangladesh due to consumption of bat-contaminated date palm sap. | |||
=== [[Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a metaanalysis and systematic review|Prevalence of posttraumatic stress disorder after infectious disease pandemics in the twenty-first century, including COVID-19: a metaanalysis and systematic review]] === | |||
'''2021''' - Molecular Psychiatry | |||
This paper provides a reliable estimate of the worldwide prevalence of PTSD after large-scale pandemics and associated risk factors, through a systematic review and meta-analysis. The study includes data on SARS, H1N1, Poliomyelitis, Ebola, Zika, Nipah, MERS-CoV, H5N1, and COVID-19. | |||
=== [[Pandemic potential of the Nipah virus and public health strategies adopted during outbreaks: Lessons from Kerala, India|Pandemic potential of the Nipah virus and public health strategies adopted during outbreaks: Lessons from Kerala, India]] === | |||
'''2024''' - PLOS GLOBAL PUBLIC HEALTH | |||
This review highlights the relevance of surveillance and health system preparedness, infection control, early diagnosis and treatment with broad-spectrum antivirals, environmental conservation, and community engagement in mitigating Nipah outbreaks. It also emphasizes the importance of developing new biologicals and anti-viral drugs to combat the disease. | |||
=== [[Smart policy changes can quell deadly Nipah virus|Smart policy changes can quell deadly Nipah virus]] === | |||
'''2024''' - Not specified in the text | |||
A paper discussing the need for smart policy changes to prevent and manage Nipah virus outbreaks, emphasizing the importance of early detection systems and infection control protocols. | |||
=== [[Nipah Virus Outbreaks in Kerala: An Impending Doom?|Nipah Virus Outbreaks in Kerala: An Impending Doom?]] === | |||
'''2024''' - Health Science Reports | |||
This paper explores ongoing challenges associated with Nipah virus transmission in Kerala, focusing on environmental factors, healthcare responses, and shifts in clinical manifestations. It highlights the need for proactive management strategies to prevent future outbreaks. | |||
=== [[Outbreak prone communicable diseases of public health importance in the northern districts of West Bengal – Current status & the way forward|Outbreak prone communicable diseases of public health importance in the northern districts of West Bengal – Current status & the way forward]] === | |||
'''2021''' - Indian J Med Res | |||
This paper discusses the current status of outbreak-prone communicable diseases in the northern districts of West Bengal, focusing on malaria, Japanese encephalitis, scrub typhus, dengue, kalaazar, and Nipah virus. It emphasizes the need for multisectoral initiatives, understanding human-animal-vector dynamics, and strengthening healthcare setup. | |||
=== [[Concern over Nipah virus cases amidst the COVID‐19 pandemic in India|Concern over Nipah virus cases amidst the COVID‐19 pandemic in India]] === | |||
'''2022''' - Journal of Medical Virology | |||
This letter discusses the concern over Nipah virus cases in India during the COVID-19 pandemic and the lack of specific pharmacological treatment for Nipah virus. | |||
=== [[Langya henipavirus: Is it a potential cause for public health concern?|Langya henipavirus: Is it a potential cause for public health concern?]] === | |||
'''2023''' - VIRULENCE | |||
A new virus, Langya henipavirus (LayV), has been identified in China and has infected 35 individuals as of August 2021, causing respiratory symptoms but no known human fatalities. LayV is genetically related to Nipah and Hendra viruses, which can cause fatal human diseases. | |||
=== [[Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report|Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report]] === | |||
'''2024''' - Keystone Symposia | |||
This paper presents lessons learned from the pandemic response in terms of dealing with emerging zoonotic viral diseases. | |||
=== [[Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus|Advancing the frontiers: Revolutionary control and prevention paradigms against Nipah virus]] === | |||
'''2023''' - Open Veterinary Journal | |||
This paper provides a comprehensive overview of the latest control and prevention strategies against Nipah virus, focusing on vaccine development, antiviral drug discovery, early diagnosis, surveillance, and high-level biosecurity measures. | |||
=== [[Nipah virus: a re-emerging public health concern|Nipah virus: a re-emerging public health concern]] === | |||
'''2024''' - The Lancet Microbe | |||
The paper discusses the re-emergence of Nipah virus, a highly virulent RNA virus, causing widespread zoonotic illnesses. It mentions recent outbreaks in various countries including India and Bangladesh, and the lack of licensed vaccines or specific medications for the virus. | |||
=== [[Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials|Therapeutics for Nipah virus disease: a systematic review to support prioritisation of drug candidates for clinical trials]] === | |||
'''2024''' - Review | |||
This paper reviews the safety and efficacy of therapeutic options for Nipah virus disease to prioritize drug candidates for further evaluation in clinical trials, suggesting trialling 1F5, m102.4, and remdesivir (alone or in combination) for prophylaxis and early treatment. | |||
=== [[Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response|Progress and challenges in Nipah vaccine development and licensure for epidemic preparedness and response]] === | |||
'''2025''' - Expert Review of Vaccines | |||
This paper reviews the progress and challenges in developing vaccines for Nipah virus, a high-consequence pathogen with no available vaccines or therapeutics. | |||
=== [[Emerging Nipah Virus With Pandemic Potential and High Mortality Rates: Is the Scientific Community Learning From Former Pandemics?|Emerging Nipah Virus With Pandemic Potential and High Mortality Rates: Is the Scientific Community Learning From Former Pandemics?]] === | |||
'''2025''' - Reviews in Medical Virology | |||
This paper reviews the global research history and status quo of Nipah virus (NiV), a highly pathogenic single-stranded RNA virus that could potentially trigger a pandemic. The study shows a significant correlation between the number of articles on NiV and the economic strength or intensity of financing per country, but finds a comparatively low scientific commitment in major player countries and knowledge gaps in NiV infectiology. | |||
=== [[Research on emerging infectious diseases: pros and cons of centralised government controls|Research on emerging infectious diseases: pros and cons of centralised government controls]] === | |||
'''2024''' - Indian J Med Ethics | |||
This paper discusses the benefits and drawbacks of centralized government control in research on emerging infectious diseases, focusing on the case study of Nipah virus research in Kerala. | |||
=== [[Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India|Experiential learnings from the Nipah virus outbreaks in Kerala towards containment of infectious public health emergencies in India]] === | |||
'''2020''' - Epidemiology and Infection | |||
This paper describes the response and control measures taken by the Indian Council of Medical Research and Kerala State Government to contain a Nipah virus outbreak in Ernakulam district, India. | |||
=== [[Emerging zoonotic diseases in Southeast Asia in the period 2011–2022: a systematic literature review|Emerging zoonotic diseases in Southeast Asia in the period 2011–2022: a systematic literature review]] === | |||
'''2024''' - Veterinary Quarterly | |||
This paper conducts a systematic literature review of the prevalence of emerging zoonotic diseases in Southeast Asia from 2011 to 2022. | |||
=== [[Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials|Current progress towards prevention of Nipah and Hendra disease in humans: A scoping review of vaccine and monoclonal antibody candidates being evaluated in clinical trials]] === | |||
'''2024''' - None | |||
This paper reviews clinical trials for vaccine and monoclonal antibody candidates designed to prevent Nipah and Hendra diseases in humans. | |||
=== [[Major zoonotic diseases of public health importance in Bangladesh|Major zoonotic diseases of public health importance in Bangladesh]] === | |||
'''2021''' - Veterinary Medicine and Science | |||
This paper reviews major zoonotic diseases that have caused outbreaks in humans in Bangladesh, such as Nipah virus and highly pathogenic avian influenza. | |||
=== [[Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures|Hendra virus: Epidemiology dynamics in relation to climate change, diagnostic tests and control measures]] === | |||
'''2021''' - One Health | |||
This paper reviews Hendra virus epidemiology, presents a biosecurity protocol for veterinary clinics, and describes diagnostic tests currently available and under development. | |||
=== [[Nipah Virus Disease: Recent Perspective and One Health Approach|Nipah Virus Disease: Recent Perspective and One Health Approach]] === | |||
'''2021''' - Annals of Global Health | |||
The paper presents a summary of the re-emergence and response to Nipah virus outbreaks in Kerala, India in 2018 and 2019. It highlights the involvement of various stakeholders in managing the outbreak and advocates for the 'One Health approach' in public health. | |||
=== [[Beyond the Headlines: Why Henipaviruses Warrant Our Attention|Beyond the Headlines: Why Henipaviruses Warrant Our Attention]] === | |||
'''2025''' - Acta Medica (Hradec Králové) | |||
This paper discusses the significance of henipaviruses (Hendra and Nipah viruses) as zoonotic threats with high mortality rates and limited therapeutic options. It highlights recent discoveries and the need for expanded research into effective antivirals, vaccines, and enhanced surveillance. | |||
=== [[Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis|Nipah Virus Disease: Epidemiological, Clinical, Diagnostic and Legislative Aspects of This Unpredictable Emerging Zoonosis]] === | |||
'''2023''' - Animals | |||
This review discusses the epidemiology, clinical signs, diagnosis, prevention, and legislation related to Nipah virus infection, focusing on its zoonotic potential in swine. It highlights the severity of the disease in humans and pigs, with respiratory and neurological signs and high mortality. | |||
=== [[Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases|Scoping future outbreaks: a scoping review on the outbreak prediction of the WHO Blueprint list of priority diseases]] === | |||
'''2021''' - BMJ Global Health | |||
This paper conducts a scoping review on the available evidence for predicting future outbreaks of diseases on the WHO Blueprint list, including Ebola, Marburg virus, Zika virus, Lassa fever, Nipah and Henipaviral disease, Rift Valley fever, Crimean-Congo haemorrhagic fever, Severe acute respiratory syndrome, Middle East respiratory syndrome, and Disease X. | |||
=== [[Nipah Outbreak: Is it the beginning of another pandemic in the era of COVID-19 and Zika|Nipah Outbreak: Is it the beginning of another pandemic in the era of COVID-19 and Zika]] === | |||
'''2022''' - Brain Behavior and Immunity | |||
This paper discusses the emergence of a Nipah virus case in Kerala, India amidst COVID-19 and Zika outbreaks, and its potential burden on the healthcare system. | |||
=== [[Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis|Clinical Medicine 2022 Vol 22, No 4: 348–52 - Review of Nipah virus encephalitis]] === | |||
'''2022''' - Clinical Medicine | |||
This paper reviews Nipah virus encephalitis, an emerging zoonotic disease causing fatal encephalitis endemic to southeast Asia and the western Pacific. The review discusses its transmission, clinical presentation, and importance for UK clinicians to consider in returning travellers. | |||
=== [[Virology | Review: Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics|Virology | Review: Henipaviruses: epidemiology, ecology, disease, and the development of vaccines and therapeutics]] === | |||
'''2024''' - Journal Name (not provided in the text) | |||
This paper reviews the epidemiology, ecology, disease, and development of vaccines and therapeutics for Henipaviruses, focusing on Hendra virus, Nipah virus, and their related viruses. | |||
=== [[Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness|Recurrent Nipah outbreaks in Kerala: implications for health policy and preparedness]] === | |||
'''2024''' - Front. Public Health | |||
This paper discusses the epidemiology of Nipah virus infection in Kerala, India, offering insights for future health policies to enhance preparedness for future outbreaks. | |||
=== [[Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?|Praemonitus praemunitus: can we forecast and prepare for future viral disease outbreaks?]] === | |||
'''2023''' - FEMS Microbiology Reviews | |||
This paper discusses the importance of learning from past pandemics to predict and minimize future viral outbreaks, focusing on viruses such as SARS-CoV-2, MERS-CoV, DENV, ZIKV, MAYV, LASV, noroviruses, influenza, Nipah virus, hantaviruses, Oropouche virus, MARV, and Ebola virus. | |||
=== [[jme-2023-109469|jme-2023-109469]] === | |||
'''None''' - Unknown | |||
Extraction failed | |||
=== [[Emerging and re-emerging viral infections in India|Emerging and re-emerging viral infections in India]] === | |||
'''2021''' - J Prev Med Hyg | |||
The number of outbreaks of viral infections like Nipah, Zika, Crimean-Congo Haemorrhagic Fever, Kyasanur Forest Disease, and currently COVID-19 have been increasing in India for many years. There is a need for better surveillance, disease burden assessments, understanding vector biology, mapping endemic areas, strengthening intersectoral coordination, improving infection control practices, and ensuring the availability of Personal Protective Equipment’s, drugs, and vaccines. | |||
=== [[Newly outbreak of Nipah virus: epidemiology, symptoms, transmission, diagnostic testing, treatment, and global health concern|Newly outbreak of Nipah virus: epidemiology, symptoms, transmission, diagnostic testing, treatment, and global health concern]] === | |||
'''2024''' - Not specified in the provided text | |||
The paper discusses the epidemiology, symptoms, transmission methods, diagnostic testing, and treatment of Nipah virus, highlighting its global health concern. | |||
=== [[Nipah amidst Covid-19 Pandemic – another Re-Emerging Infectious Disease of Pandemic Potential – a Narrative Review|Nipah amidst Covid-19 Pandemic – another Re-Emerging Infectious Disease of Pandemic Potential – a Narrative Review]] === | |||
'''2022''' - Maedica – a Journal of Clinical Medicine | |||
This paper is a narrative review discussing the history and recent outbreaks of Nipah virus, focusing on its detection in Kerala with the Malaysian variant. | |||
=== [[Addressing the recurrent Nipah Virus outbreaks: A call for vigilance, collaboration, and preparedness|Addressing the recurrent Nipah Virus outbreaks: A call for vigilance, collaboration, and preparedness]] === | |||
'''2023''' - New Microbes and New Infections | |||
This paper calls for vigilance, collaboration, and preparedness to address the recurrent Nipah Virus outbreaks in Kerala, India. | |||
=== [[Navigating Nipah virus: Insights, challenges, and recommendations|Navigating Nipah virus: Insights, challenges, and recommendations]] === | |||
'''2025''' - New Microbes and New Infections | |||
This paper discusses the challenges posed by Nipah virus, a zoonotic pathogen, focusing on its diverse strains, recurrent outbreaks, diagnostic limitations, and the need for therapeutic advancements. | |||
=== [[Emerging threat: Nipah virus - A call for global preparedness and vigilance|Emerging threat: Nipah virus - A call for global preparedness and vigilance]] === | |||
'''2024''' - New Microbes and New Infections | |||
The paper discusses the emergence of Nipah virus as a global public health threat, with recent outbreaks in Bangladesh raising concerns. There is currently no specific therapeutic intervention for infected individuals. | |||
=== [[Infectious disease and economics: The case for considering multi-sectoral impacts|Infectious disease and economics: The case for considering multi-sectoral impacts]] === | |||
'''2019''' - One Health | |||
This paper argues for considering the wider socioeconomic consequences of infectious disease events beyond traditional public health sectors. | |||
=== [[Assessing the feasibility of Nipah vaccine effliciency trials based on previous outbreaks in Bangladesh|Assessing the feasibility of Nipah vaccine effliciency trials based on previous outbreaks in Bangladesh]] === | |||
'''2021''' - Vaccine | |||
This paper investigates the feasibility of conducting a phase III Nipah vaccine trial in Bangladesh using simulations based on previous outbreaks. | |||
=== [[A systematic review of case reports on mortality, modes of infection, diagnostic tests, and treatments for Nipah virus infection|A systematic review of case reports on mortality, modes of infection, diagnostic tests, and treatments for Nipah virus infection]] === | |||
'''2024''' - Medicine® | |||
This paper conducts a systematic review of case reports on Nipah virus infection to examine geographic distribution, mortality, transmission pathways, and available methods for diagnosis and treatment. | |||
=== [[Nipah Virus: A Zoonotic Threat Re-Emerging in the Wake of Global Public Health Challenges|Nipah Virus: A Zoonotic Threat Re-Emerging in the Wake of Global Public Health Challenges]] === | |||
'''2025''' - Microorganisms | |||
This paper explores the re-emergence of the Nipah virus in Kerala, India, highlighting its critical concern for health authorities due to high fatality rates and lack of vaccine or curative treatment. | |||
=== [[Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic|Nipah virus: a potential pandemic agent in the context of the current severe acute respiratory syndrome coronavirus 2 pandemic]] === | |||
'''2021''' - Elsevier Ltd. | |||
This paper speculates that the Nipah virus, similar to SARS-CoV-2, could potentially cause a pandemic if not adequately researched due to its high death rate despite causing a low number of infections. | |||
=== [[Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh|Piloting the promotion of bamboo skirt barriers to prevent Nipah virus transmission through date palm sap in Bangladesh]] === | |||
'''2014''' - Glob Health Promot | |||
The study explores the effectiveness of promoting bamboo skirt preparation and use among sap harvesters in Bangladesh to prevent Nipah virus transmission through date palm sap. | |||
=== [[Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic|Nipah and Hendra Viruses: Deadly Zoonotic Paramyxoviruses with the Potential to Cause the Next Pandemic]] === | |||
'''2024''' - Pathogens | |||
This paper discusses Nipah and Hendra viruses, which are deadly zoonotic paramyxoviruses with a case fatality rate of up to 75%. The authors emphasize the need for research on these viruses due to their extreme pathogenicity, pandemic potential, and lack of established antiviral therapeutics and vaccines. | |||
=== [[Henipaviruses—A constant threat to livestock and humans|Henipaviruses—A constant threat to livestock and humans]] === | |||
'''2022''' - PLOS Neglected Tropical Diseases | |||
This review highlights the risk of infections with henipaviruses to both livestock and humans, providing a comprehensive overview of documented outbreaks, their impact on the economy and health systems. | |||
=== [[Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006–2021|Tackling a global epidemic threat: Nipah surveillance in Bangladesh, 2006–2021]] === | |||
'''2023''' - PLOS Neglected Tropical Diseases | |||
This research paper discusses a hospital-based Nipah sentinel surveillance in Bangladesh that has been ongoing since 2006 to promptly detect Nipah cases and respond to outbreaks. | |||
=== [[Saliva: An Overlooked yet Critical Diagnostic Tool in Detection of Nipah Virus|Saliva: An Overlooked yet Critical Diagnostic Tool in Detection of Nipah Virus]] === | |||
'''2024''' - Not specified (Letter to Editor) | |||
This paper emphasizes the importance of saliva samples as a non-invasive and cost-effective diagnostic tool for Nipah virus detection, enabling earlier detection and intervention. | |||
=== [[Knowledge, Attitudes, Risk Perception, Preparedness and Vaccine Intent of Health Care Providers towards the Nipah Virus in South India|Knowledge, Attitudes, Risk Perception, Preparedness and Vaccine Intent of Health Care Providers towards the Nipah Virus in South India]] === | |||
'''2022''' - Tropical Medicine and Infectious Disease | |||
This paper assesses the knowledge, attitudes, and risk perception of Nipah Virus (NVD) among healthcare providers in South India. The study found that while most participants were aware of NiV symptoms and primary reservoirs, knowledge gaps existed regarding transmission factors and institutional protocols. | |||
=== [[Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries|Nipah Virus: An Overview of the Current Status of Diagnostics and Their Role in Preparedness in Endemic Countries]] === | |||
'''2023''' - Viruses | |||
This paper provides an overview of the current status of diagnostics for Nipah virus (NiV), a high mortality rate zoonosis. Early diagnosis is crucial to limit outbreaks and provide appropriate care. qRT-PCR is currently considered optimal for acute NiV infection assessment, with different sensitivities depending on the platform used. | |||
=== [[Nipah Virus: A Multidimensional Update|Nipah Virus: A Multidimensional Update]] === | |||
'''2024''' - Viruses | |||
This paper provides an update on Nipah virus (NiV), a high mortality zoonotic paramyxovirus responsible for numerous outbreaks in South and South-East Asia. Human infection manifests as encephalitis with high mortality rates, and no therapeutic agents or vaccines have been approved for human use. | |||
=== [[Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World|Zoonotic Paramyxoviruses: Evolution, Ecology, and Public Health Strategies in a Changing World]] === | |||
'''2024''' - Not specified in the provided text | |||
This paper reviews current knowledge on emerging zoonotic paramyxoviruses, focusing on recently discovered viruses and their potential to cause future epidemics. It explores host-switching events, viral replication strategies, immune evasion tactics, ecological factors influencing virus emergence, public health impact, and the need for enhanced surveillance, improved diagnostic tools, and proactive strategies. | |||
=== [[Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis|Risk of Nipah Virus Seroprevalence in Healthcare Workers: A Systematic Review with Meta-Analysis]] === | |||
'''2025''' - Academic Editors: Marc Jamin, Glenn Marsh and Jennifer Barr | |||
This paper is a systematic review with meta-analysis on Nipah virus infections occurring in healthcare workers, estimating seroprevalence and case fatality ratio. | |||
=== [[Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India|Zika, Nipah and Kala-azar: Emerging lethal infectious diseases amid COVID-19 as an escalating public health threat in South India]] === | |||
'''2022''' - Annals of Medicine and Surgery | |||
This paper discusses the challenges presented by the intersecting outbreaks of Zika, Nipah, and Kala-azar in India amidst the COVID-19 pandemic, and provides recommendations to help alleviate the situation. | |||
=== [[Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralization studies|Highly sensitive and quantitative HiBiT-tagged Nipah virus-like particles: A platform for rapid antibody neutralization studies]] === | |||
'''2024''' - Heliyon | |||
This paper synthesizes HiBiT-tagged Nipah virus-like particles for in vitro BSL-2 handling and rapid antibody neutralization studies. | |||
=== [[Structural and functional analysis of the Nipah virus polymerase complex|Structural and functional analysis of the Nipah virus polymerase complex]] === | |||
'''2025''' - Cell | |||
The paper determines the cryoelectron microscopy (cryo-EM) structure of the Nipah virus polymerase complex and performs structural, biophysical, and functional analyses to understand features critical for RNA replication and transcription. The findings could aid in the development of antivirals. | |||
=== [[Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species|Prophylactic protection from lethal henipavirus disease mediated by Nipah-derived defective interfering particles is influenced by challenge virus strain and viral species]] === | |||
'''2025''' - eBioMedicine | |||
The paper explores the effectiveness of defective interfering particles (DIPs) in reducing clinical signs and lethality of henipavirus infection in Syrian hamsters. | |||
=== [[Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition|Co-evolution of SARS-CoV-2 variants and host immune response trajectories underlie COVID-19 pandemic to epidemic transition]] === | |||
'''2023''' - iScience | |||
The study investigates the differential host-immune kinetics associated with SARS-CoV-2 variants during different time periods of Pre-VOC and VOCs (Delta & Omicron). The findings suggest that Omicron infection is marked by a robust type 1 interferon response, which was largely missing during Pre-VOC and Delta waves. The study highlights the eventual adaptation of host to immune activation patterns that interrupt virus evolution with enhanced immune-evasion mutations and counteraction mechanisms. | |||
=== [[Bats as reservoirs of severe emerging infectious diseases|Bats as reservoirs of severe emerging infectious diseases]] === | |||
'''2015''' - Virus Research | |||
This paper discusses how bats are reservoirs for several severe emerging infectious diseases, including Ebola virus, SARS coronavirus, MERS coronavirus, Nipah virus, and Hendra virus. | |||
Latest revision as of 02:01, 7 February 2026
2024 - The Lancet Regional Health - Southeast Asia
This paper discusses strategies to improve the clinical care for patients in Nipah outbreaks, focusing on enhancing early case detection, optimizing supportive care, adopting a syndromic approach, and exploring innovative trial designs. The goal is to better equip healthcare systems in Nipah-endemic regions to manage current and future outbreaks.
2022 - Annals of Medicine and Surgery
This paper discusses the recent re-emergence of Nipah virus (NiV) in India's Kozhikode district, causing the death of a 12-year-old boy. The authors aim to suggest recommendations to contain and mitigate the severe impact of the virus on affected populations.
2021 - Vaccine
A protein vaccine for Nipah and Hendra viruses is under clinical evaluation in a Phase 1 study. The paper discusses the standardized template to describe key considerations for the benefit-risk assessment of this type of vaccine.
2025 - Vaccine
This paper explores people's knowledge about Nipah virus and their willingness to participate in a vaccine trial in Bangladesh.
2025 - Journal of Infection and Public Health
This paper provides an overview of the scientific landscape, highlights research focus areas, and outlines potential future investigations on Langya henipavirus. It was done via a systematic review and bibliometric analysis over the past two decades.
2022 - GeroScience
This paper reviews the pathogenicity and interaction with the human immune system of Nipah virus (NiV) and Hendra virus (HeV), highly pathogenic zoonotic viruses that can cause severe disease in humans and various mammalian species.
2025 - Virology Journal
This paper reviews the epidemiology, clinical features, and modes of transmission of Nipah virus infection, its geographical distribution, and endemic regions.
2017 - BMC Research Notes
This paper measures the cost of an intervention to prevent Nipah transmission in Bangladesh and estimates the cost of scaling it up in districts where spillover has been identified.
2024 - Journal of Health, Population and Nutrition
This paper reviews the Nipah Virus (NiV), an emerging zoonotic disease primarily found in Southeast Asian regions with the highest number of cases in Bangladesh and India. The virus has a high fatality rate and there is no approved treatment or vaccine.
2023 - Tropical Medicine and Health
This paper reviews the epidemiology, pathogenesis, molecular surveillance, transmission dynamics, genetic diversity, reservoir host, clinical characteristics, and phylogenetics of Nipah virus in South and South East Asia.
2015 - Journal of Public Health Policy
This paper discusses policy options for controlling Nipah virus encephalitis in Bangladesh due to consumption of bat-contaminated date palm sap.
2021 - Molecular Psychiatry
This paper provides a reliable estimate of the worldwide prevalence of PTSD after large-scale pandemics and associated risk factors, through a systematic review and meta-analysis. The study includes data on SARS, H1N1, Poliomyelitis, Ebola, Zika, Nipah, MERS-CoV, H5N1, and COVID-19.
2024 - PLOS GLOBAL PUBLIC HEALTH
This review highlights the relevance of surveillance and health system preparedness, infection control, early diagnosis and treatment with broad-spectrum antivirals, environmental conservation, and community engagement in mitigating Nipah outbreaks. It also emphasizes the importance of developing new biologicals and anti-viral drugs to combat the disease.
2024 - Not specified in the text
A paper discussing the need for smart policy changes to prevent and manage Nipah virus outbreaks, emphasizing the importance of early detection systems and infection control protocols.
2024 - Health Science Reports
This paper explores ongoing challenges associated with Nipah virus transmission in Kerala, focusing on environmental factors, healthcare responses, and shifts in clinical manifestations. It highlights the need for proactive management strategies to prevent future outbreaks.
2021 - Indian J Med Res
This paper discusses the current status of outbreak-prone communicable diseases in the northern districts of West Bengal, focusing on malaria, Japanese encephalitis, scrub typhus, dengue, kalaazar, and Nipah virus. It emphasizes the need for multisectoral initiatives, understanding human-animal-vector dynamics, and strengthening healthcare setup.
2022 - Journal of Medical Virology
This letter discusses the concern over Nipah virus cases in India during the COVID-19 pandemic and the lack of specific pharmacological treatment for Nipah virus.
2023 - VIRULENCE
A new virus, Langya henipavirus (LayV), has been identified in China and has infected 35 individuals as of August 2021, causing respiratory symptoms but no known human fatalities. LayV is genetically related to Nipah and Hendra viruses, which can cause fatal human diseases.
Lessons from the pandemic: Responding to emerging zoonotic viral diseases—a Keystone Symposia report
2024 - Keystone Symposia
This paper presents lessons learned from the pandemic response in terms of dealing with emerging zoonotic viral diseases.
2023 - Open Veterinary Journal
This paper provides a comprehensive overview of the latest control and prevention strategies against Nipah virus, focusing on vaccine development, antiviral drug discovery, early diagnosis, surveillance, and high-level biosecurity measures.
2024 - The Lancet Microbe
The paper discusses the re-emergence of Nipah virus, a highly virulent RNA virus, causing widespread zoonotic illnesses. It mentions recent outbreaks in various countries including India and Bangladesh, and the lack of licensed vaccines or specific medications for the virus.
2024 - Review
This paper reviews the safety and efficacy of therapeutic options for Nipah virus disease to prioritize drug candidates for further evaluation in clinical trials, suggesting trialling 1F5, m102.4, and remdesivir (alone or in combination) for prophylaxis and early treatment.
2025 - Expert Review of Vaccines
This paper reviews the progress and challenges in developing vaccines for Nipah virus, a high-consequence pathogen with no available vaccines or therapeutics.
2025 - Reviews in Medical Virology
This paper reviews the global research history and status quo of Nipah virus (NiV), a highly pathogenic single-stranded RNA virus that could potentially trigger a pandemic. The study shows a significant correlation between the number of articles on NiV and the economic strength or intensity of financing per country, but finds a comparatively low scientific commitment in major player countries and knowledge gaps in NiV infectiology.
2024 - Indian J Med Ethics
This paper discusses the benefits and drawbacks of centralized government control in research on emerging infectious diseases, focusing on the case study of Nipah virus research in Kerala.
2020 - Epidemiology and Infection
This paper describes the response and control measures taken by the Indian Council of Medical Research and Kerala State Government to contain a Nipah virus outbreak in Ernakulam district, India.
Emerging zoonotic diseases in Southeast Asia in the period 2011–2022: a systematic literature review
2024 - Veterinary Quarterly
This paper conducts a systematic literature review of the prevalence of emerging zoonotic diseases in Southeast Asia from 2011 to 2022.
2024 - None
This paper reviews clinical trials for vaccine and monoclonal antibody candidates designed to prevent Nipah and Hendra diseases in humans.
2021 - Veterinary Medicine and Science
This paper reviews major zoonotic diseases that have caused outbreaks in humans in Bangladesh, such as Nipah virus and highly pathogenic avian influenza.
2021 - One Health
This paper reviews Hendra virus epidemiology, presents a biosecurity protocol for veterinary clinics, and describes diagnostic tests currently available and under development.
2021 - Annals of Global Health
The paper presents a summary of the re-emergence and response to Nipah virus outbreaks in Kerala, India in 2018 and 2019. It highlights the involvement of various stakeholders in managing the outbreak and advocates for the 'One Health approach' in public health.
2025 - Acta Medica (Hradec Králové)
This paper discusses the significance of henipaviruses (Hendra and Nipah viruses) as zoonotic threats with high mortality rates and limited therapeutic options. It highlights recent discoveries and the need for expanded research into effective antivirals, vaccines, and enhanced surveillance.
2023 - Animals
This review discusses the epidemiology, clinical signs, diagnosis, prevention, and legislation related to Nipah virus infection, focusing on its zoonotic potential in swine. It highlights the severity of the disease in humans and pigs, with respiratory and neurological signs and high mortality.
2021 - BMJ Global Health
This paper conducts a scoping review on the available evidence for predicting future outbreaks of diseases on the WHO Blueprint list, including Ebola, Marburg virus, Zika virus, Lassa fever, Nipah and Henipaviral disease, Rift Valley fever, Crimean-Congo haemorrhagic fever, Severe acute respiratory syndrome, Middle East respiratory syndrome, and Disease X.
2022 - Brain Behavior and Immunity
This paper discusses the emergence of a Nipah virus case in Kerala, India amidst COVID-19 and Zika outbreaks, and its potential burden on the healthcare system.
2022 - Clinical Medicine
This paper reviews Nipah virus encephalitis, an emerging zoonotic disease causing fatal encephalitis endemic to southeast Asia and the western Pacific. The review discusses its transmission, clinical presentation, and importance for UK clinicians to consider in returning travellers.
2024 - Journal Name (not provided in the text)
This paper reviews the epidemiology, ecology, disease, and development of vaccines and therapeutics for Henipaviruses, focusing on Hendra virus, Nipah virus, and their related viruses.
2024 - Front. Public Health
This paper discusses the epidemiology of Nipah virus infection in Kerala, India, offering insights for future health policies to enhance preparedness for future outbreaks.
2023 - FEMS Microbiology Reviews
This paper discusses the importance of learning from past pandemics to predict and minimize future viral outbreaks, focusing on viruses such as SARS-CoV-2, MERS-CoV, DENV, ZIKV, MAYV, LASV, noroviruses, influenza, Nipah virus, hantaviruses, Oropouche virus, MARV, and Ebola virus.
None - Unknown
Extraction failed
2021 - J Prev Med Hyg
The number of outbreaks of viral infections like Nipah, Zika, Crimean-Congo Haemorrhagic Fever, Kyasanur Forest Disease, and currently COVID-19 have been increasing in India for many years. There is a need for better surveillance, disease burden assessments, understanding vector biology, mapping endemic areas, strengthening intersectoral coordination, improving infection control practices, and ensuring the availability of Personal Protective Equipment’s, drugs, and vaccines.
2024 - Not specified in the provided text
The paper discusses the epidemiology, symptoms, transmission methods, diagnostic testing, and treatment of Nipah virus, highlighting its global health concern.
2022 - Maedica – a Journal of Clinical Medicine
This paper is a narrative review discussing the history and recent outbreaks of Nipah virus, focusing on its detection in Kerala with the Malaysian variant.
2023 - New Microbes and New Infections
This paper calls for vigilance, collaboration, and preparedness to address the recurrent Nipah Virus outbreaks in Kerala, India.
2025 - New Microbes and New Infections
This paper discusses the challenges posed by Nipah virus, a zoonotic pathogen, focusing on its diverse strains, recurrent outbreaks, diagnostic limitations, and the need for therapeutic advancements.
2024 - New Microbes and New Infections
The paper discusses the emergence of Nipah virus as a global public health threat, with recent outbreaks in Bangladesh raising concerns. There is currently no specific therapeutic intervention for infected individuals.
2019 - One Health
This paper argues for considering the wider socioeconomic consequences of infectious disease events beyond traditional public health sectors.
2021 - Vaccine
This paper investigates the feasibility of conducting a phase III Nipah vaccine trial in Bangladesh using simulations based on previous outbreaks.
2024 - Medicine®
This paper conducts a systematic review of case reports on Nipah virus infection to examine geographic distribution, mortality, transmission pathways, and available methods for diagnosis and treatment.
2025 - Microorganisms
This paper explores the re-emergence of the Nipah virus in Kerala, India, highlighting its critical concern for health authorities due to high fatality rates and lack of vaccine or curative treatment.
2021 - Elsevier Ltd.
This paper speculates that the Nipah virus, similar to SARS-CoV-2, could potentially cause a pandemic if not adequately researched due to its high death rate despite causing a low number of infections.
2014 - Glob Health Promot
The study explores the effectiveness of promoting bamboo skirt preparation and use among sap harvesters in Bangladesh to prevent Nipah virus transmission through date palm sap.
2024 - Pathogens
This paper discusses Nipah and Hendra viruses, which are deadly zoonotic paramyxoviruses with a case fatality rate of up to 75%. The authors emphasize the need for research on these viruses due to their extreme pathogenicity, pandemic potential, and lack of established antiviral therapeutics and vaccines.
2022 - PLOS Neglected Tropical Diseases
This review highlights the risk of infections with henipaviruses to both livestock and humans, providing a comprehensive overview of documented outbreaks, their impact on the economy and health systems.
2023 - PLOS Neglected Tropical Diseases
This research paper discusses a hospital-based Nipah sentinel surveillance in Bangladesh that has been ongoing since 2006 to promptly detect Nipah cases and respond to outbreaks.
2024 - Not specified (Letter to Editor)
This paper emphasizes the importance of saliva samples as a non-invasive and cost-effective diagnostic tool for Nipah virus detection, enabling earlier detection and intervention.
2022 - Tropical Medicine and Infectious Disease
This paper assesses the knowledge, attitudes, and risk perception of Nipah Virus (NVD) among healthcare providers in South India. The study found that while most participants were aware of NiV symptoms and primary reservoirs, knowledge gaps existed regarding transmission factors and institutional protocols.
2023 - Viruses
This paper provides an overview of the current status of diagnostics for Nipah virus (NiV), a high mortality rate zoonosis. Early diagnosis is crucial to limit outbreaks and provide appropriate care. qRT-PCR is currently considered optimal for acute NiV infection assessment, with different sensitivities depending on the platform used.
2024 - Viruses
This paper provides an update on Nipah virus (NiV), a high mortality zoonotic paramyxovirus responsible for numerous outbreaks in South and South-East Asia. Human infection manifests as encephalitis with high mortality rates, and no therapeutic agents or vaccines have been approved for human use.
2024 - Not specified in the provided text
This paper reviews current knowledge on emerging zoonotic paramyxoviruses, focusing on recently discovered viruses and their potential to cause future epidemics. It explores host-switching events, viral replication strategies, immune evasion tactics, ecological factors influencing virus emergence, public health impact, and the need for enhanced surveillance, improved diagnostic tools, and proactive strategies.
2025 - Academic Editors: Marc Jamin, Glenn Marsh and Jennifer Barr
This paper is a systematic review with meta-analysis on Nipah virus infections occurring in healthcare workers, estimating seroprevalence and case fatality ratio.
2022 - Annals of Medicine and Surgery
This paper discusses the challenges presented by the intersecting outbreaks of Zika, Nipah, and Kala-azar in India amidst the COVID-19 pandemic, and provides recommendations to help alleviate the situation.
2024 - Heliyon
This paper synthesizes HiBiT-tagged Nipah virus-like particles for in vitro BSL-2 handling and rapid antibody neutralization studies.
2025 - Cell
The paper determines the cryoelectron microscopy (cryo-EM) structure of the Nipah virus polymerase complex and performs structural, biophysical, and functional analyses to understand features critical for RNA replication and transcription. The findings could aid in the development of antivirals.
2025 - eBioMedicine
The paper explores the effectiveness of defective interfering particles (DIPs) in reducing clinical signs and lethality of henipavirus infection in Syrian hamsters.
2023 - iScience
The study investigates the differential host-immune kinetics associated with SARS-CoV-2 variants during different time periods of Pre-VOC and VOCs (Delta & Omicron). The findings suggest that Omicron infection is marked by a robust type 1 interferon response, which was largely missing during Pre-VOC and Delta waves. The study highlights the eventual adaptation of host to immune activation patterns that interrupt virus evolution with enhanced immune-evasion mutations and counteraction mechanisms.
2015 - Virus Research
This paper discusses how bats are reservoirs for several severe emerging infectious diseases, including Ebola virus, SARS coronavirus, MERS coronavirus, Nipah virus, and Hendra virus.